Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7501784rdf:typepubmed:Citationlld:pubmed
pubmed-article:7501784lifeskim:mentionsumls-concept:C0040479lld:lifeskim
pubmed-article:7501784lifeskim:mentionsumls-concept:C0018546lld:lifeskim
pubmed-article:7501784lifeskim:mentionsumls-concept:C0004083lld:lifeskim
pubmed-article:7501784lifeskim:mentionsumls-concept:C0348016lld:lifeskim
pubmed-article:7501784lifeskim:mentionsumls-concept:C0282441lld:lifeskim
pubmed-article:7501784lifeskim:mentionsumls-concept:C0868928lld:lifeskim
pubmed-article:7501784pubmed:issue6lld:pubmed
pubmed-article:7501784pubmed:dateCreated1996-1-18lld:pubmed
pubmed-article:7501784pubmed:abstractTextTorsades de Pointes (TDP) is a potentially malignant ventricular arrhythmia that often has a drug-induced origin. Oral, but not intravenous, haloperidol has been generally associated with this arrhythmia. The authors detail three patient cases of TDP that occurred while the patients were receiving intravenous haloperidol. The authors discuss the known risk factors for the development of TDP and review the literature on ventricular arrhythmias associated with haloperidol use.lld:pubmed
pubmed-article:7501784pubmed:languageenglld:pubmed
pubmed-article:7501784pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7501784pubmed:citationSubsetIMlld:pubmed
pubmed-article:7501784pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7501784pubmed:statusMEDLINElld:pubmed
pubmed-article:7501784pubmed:issn0033-3182lld:pubmed
pubmed-article:7501784pubmed:authorpubmed-author:SternT ATAlld:pubmed
pubmed-article:7501784pubmed:authorpubmed-author:HuntNNlld:pubmed
pubmed-article:7501784pubmed:issnTypePrintlld:pubmed
pubmed-article:7501784pubmed:volume36lld:pubmed
pubmed-article:7501784pubmed:ownerNLMlld:pubmed
pubmed-article:7501784pubmed:authorsCompleteYlld:pubmed
pubmed-article:7501784pubmed:pagination541-9lld:pubmed
pubmed-article:7501784pubmed:dateRevised2005-11-16lld:pubmed
pubmed-article:7501784pubmed:meshHeadingpubmed-meshheading:7501784-...lld:pubmed
pubmed-article:7501784pubmed:meshHeadingpubmed-meshheading:7501784-...lld:pubmed
pubmed-article:7501784pubmed:meshHeadingpubmed-meshheading:7501784-...lld:pubmed
pubmed-article:7501784pubmed:meshHeadingpubmed-meshheading:7501784-...lld:pubmed
pubmed-article:7501784pubmed:meshHeadingpubmed-meshheading:7501784-...lld:pubmed
pubmed-article:7501784pubmed:meshHeadingpubmed-meshheading:7501784-...lld:pubmed
pubmed-article:7501784pubmed:meshHeadingpubmed-meshheading:7501784-...lld:pubmed
pubmed-article:7501784pubmed:meshHeadingpubmed-meshheading:7501784-...lld:pubmed
pubmed-article:7501784pubmed:meshHeadingpubmed-meshheading:7501784-...lld:pubmed
pubmed-article:7501784pubmed:meshHeadingpubmed-meshheading:7501784-...lld:pubmed
pubmed-article:7501784pubmed:meshHeadingpubmed-meshheading:7501784-...lld:pubmed
pubmed-article:7501784pubmed:meshHeadingpubmed-meshheading:7501784-...lld:pubmed
pubmed-article:7501784pubmed:articleTitleThe association between intravenous haloperidol and Torsades de Pointes. Three cases and a literature review.lld:pubmed
pubmed-article:7501784pubmed:affiliationDepartment of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, USA.lld:pubmed
pubmed-article:7501784pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7501784pubmed:publicationTypeReviewlld:pubmed
pubmed-article:7501784pubmed:publicationTypeCase Reportslld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7501784lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7501784lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7501784lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7501784lld:pubmed